Superoxide mediates the actions of angiotensin II in the central nervous system

被引:332
作者
Zimmerman, MC
Lazartigues, E
Lang, JA
Sinnayah, P
Ahmad, IM
Spitz, DR
Davisson, RL
机构
[1] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Anat & Cell Biol, Iowa City, IA 52242 USA
[2] Univ Iowa, Roy J & Lucille A Carver Coll Med, Free Rad & Radiat Biol Program, Dept Radiat Oncol, Iowa City, IA 52242 USA
关键词
blood pressure; thirst; reactive oxygen species; renin-angiotensin system; brain;
D O I
10.1161/01.RES.0000043501.47934.FA
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Angiotensin II (Ang II) has profound effects in the central nervous system (CNS), including promotion of thirst, regulation of vasopressin secretion, and modulation of sympathetic outflow. Despite its importance in cardiovascular and volume homeostasis, angiotensinergic mechanisms are incompletely understood in the CNS. Recently, a novel signaling mechanism for Ang II involving reactive oxygen species (ROS) has been identified in a variety of peripheral tissues, but the involvement of ROS as second messengers in Ang II-mediated signaling in the CNS has not been reported. The hypothesis that superoxide is a key mediator of the actions of Ang II in the CNS was tested in mice using adenoviral vector-mediated expression of superoxide dismutase (AdSOD). Changes in blood pressure, heart rate, and drinking elicited by injection of Ang H in the CNS were abolished by prior treatment with AdSOD in the brain, where-as the cardiovascular responses to carbachol, another central vasopressor agent, were unaffected. In addition, Ang II stimulated superoxide generation in primary CNS cell cultures, and this was prevented by the Ang H receptor (Ang II type I subtype) antagonist losartan or AdSOD. These results identify a novel signaling mechanism mediating the actions of Ang II in the CNS. Dysregulation of this signaling cascade may be important in hypertension and heart failure triggered by Ang II acting in the CNS.
引用
收藏
页码:1038 / 1045
页数:8
相关论文
共 43 条
[21]  
LIND RW, 1985, NEUROENDOCRINOLOGY, V40, P2
[22]   ANGIOTENSIN-II IMMUNOREACTIVITY IN THE NEURAL AFFERENTS AND EFFERENTS OF THE SUBFORNICAL ORGAN OF THE RAT [J].
LIND, RW ;
SWANSON, LW ;
GANTEN, D .
BRAIN RESEARCH, 1984, 321 (02) :209-215
[23]  
LIND RW, 1982, J NEUROSCI, V2, P1043
[24]  
Lindenau J, 2000, GLIA, V29, P25, DOI 10.1002/(SICI)1098-1136(20000101)29:1<25::AID-GLIA3>3.0.CO
[25]  
2-G
[26]  
LOWRY OH, 1951, J BIOL CHEM, V193, P265
[27]   ROLE OF ENDOGENOUS ANGIOTENSIN-II IN THE CONTROL OF VASOPRESSIN SECRETION DURING HYPOVOLEMIA AND HYPOTENSION IN CONSCIOUS RABBITS [J].
MATSUKAWA, S ;
KEIL, LC ;
REID, IA .
ENDOCRINOLOGY, 1991, 128 (01) :204-210
[28]   A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase [J].
Melov, S ;
Schneider, JA ;
Day, BJ ;
Hinerfeld, D ;
Coskun, P ;
Mirra, SS ;
Crapo, JD ;
Wallace, DC .
NATURE GENETICS, 1998, 18 (02) :159-163
[29]   Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-a and angiotensin II [J].
Nakamura, K ;
Fushimi, K ;
Kouchi, H ;
Mihara, K ;
Miyazaki, M ;
Ohe, T ;
Namba, M .
CIRCULATION, 1998, 98 (08) :794-799
[30]   Angiotensin II in central nervous system physiology [J].
Phillips, MI ;
Sumners, C .
REGULATORY PEPTIDES, 1998, 78 (1-3) :1-11